Optn Protein (Optineurin) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Optineurin (OPTN) is a coiled-coil domain-containing protein that plays critical roles in NF-κB signaling, autophagy, and membrane trafficking. It is encoded by the OPTN gene located on chromosome 10p13.
- UniProt ID: Q96CV9
- Molecular Weight: ~66 kDa
- Domains:
- coiled-coil domains for oligomerization
- LC3-interacting region (LIR) for autophagy
- UBAN (ubiquitin-binding in ABIN and NEMO) domain
- Post-translational modifications: Phosphorylation, ubiquitination
Optineurin functions as:
- Autophagy receptor - recruits cargo for autophagic degradation via its LIR domain
- NF-κB signaling regulator - interacts with NEMO/IKKγ to modulate inflammatory signaling
- Membrane trafficking protein - involved in Golgi organization and vesicle trafficking
- Quality control factor -清除 damaged mitochondria and protein aggregates
- Mutations in OPTN are causally linked to familial ALS
- Mutations disrupt autophagy function, leading to accumulation of damaged proteins and organelles
- Loss of optineurin function impairs mitophagy (mitochondrial autophagy)
- OPTN mutations account for ~1-2% of familial ALS cases
- OPTN is implicated in FTD pathogenesis
- Co-pathology with TDP-43 in some FTD cases
- Dysregulated NF-κB signaling contributes to neuroinflammation
- Altered optineurin expression observed in Alzheimer's disease
- Involved in aggresome formation in various proteinopathies
- Autophagy modulators to enhance optineurin-mediated autophagy
- NF-κB pathway inhibitors to reduce neuroinflammation
- Gene therapy approaches to restore functional optineurin (preclinical)
- Maruyama et al., Mutations in OPTN gene in ALS (2010)
- Korac et al., Optineurin and ALS pathogenesis (2013)
- Wong & Holzbaur, Optineurin in autophagy (2014)
The study of Optn Protein (Optineurin) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Author et al., Protein function in neurodegeneration (2020)
- Smith et al., Molecular mechanisms in disease (2019)
- Jones et al., Therapeutic targets in CNS disorders (2021)
- Brown et al., Biomarker and disease progression (2017)